Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia × Razoxane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Cardiotoxicity 5 Sarcoma 3 Lymphoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroblastoma 2 Lymphoma, Large-Cell, Anaplastic 2 Leukemia, Myeloid, Acute 2 Leukemia, Biphenotypic, Acute 2 Ganglioneuroblastoma 2 Burkitt Lymphoma 2 Blast Crisis 2 Sezary Syndrome 1 Sarcoma, Synovial 1 Sarcoma, Myeloid 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 PRETEXT I Hepatoblastoma 1 Osteosarcoma 1 Neurofibrosarcoma 1 Myeloproliferative Disorders 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Extranodal NK-T-Cell 1 Localized Extraskeletal Ewing Sarcoma 1 Liposarcoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1

Interventions

Cyclophosphamide 318 Cytarabine 259 fludarabine phosphate 178 Methotrexate 163 Filgrastim 143 Etoposide 128 Busulfan 128 fludarabine 114 Rituximab 114 Peripheral Blood Stem Cell Transplantation 112 Radiotherapy 101 Vincristine 93 Cyclosporine 87 Daunorubicin 84 Dexamethasone 83 Antilymphocyte Serum 83 Mycophenolic Acid 75 Melphalan 75 Whole-Body Irradiation 74 Tacrolimus 71 Imatinib Mesylate 64 Idarubicin 64 Azacitidine 60 Mercaptopurine 58 Granulocyte Colony-Stimulating Factor 55 Doxorubicin 54 Methylprednisolone 53 Prednisone 51 Mitoxantrone 48 Clofarabine 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01230983 2013-06-06

T-Cell #4

Children's Oncology Group

Phase 3 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡